Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)
Clinical trial NCT00813332 · UNKNOWN
Trial details
- NCT number
- NCT00813332
- Sponsor
- Simcere Pharmaceutical Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-10-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.